Three cases of immune-related hypopituitarism after atezolizumab-bevacizumab treatment for hepatocellular carcinoma.
Clin J Gastroenterol
; 16(3): 422-431, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-36821067
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Hyponatremia
/
Liver Neoplasms
Limits:
Humans
/
Male
Language:
En
Journal:
Clin J Gastroenterol
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
Japan